Volume 73, Issue 12, Pages (June 2008)

Slides:



Advertisements
Similar presentations
Volume 62, Issue 6, Pages (December 2002)
Advertisements

Volume 78, Issue 1, Pages (July 2010)
Lymphatic vessels develop during tubulointerstitial fibrosis
Volume 62, Issue 1, Pages (July 2002)
Acute interstitial nephritis
Tiffany Shao, Jordan Weinstein, Serge Jothy, Marc Goldstein 
Lakhmir S. Chawla, Paul L. Kimmel  Kidney International 
An active renal crystal clearance mechanism in rat and man
The Case | Renal failure in a bodybuilder athlete
Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis  Akira Shimizu, Kazuhiko Yamada, David.
Volume 65, Issue 5, Pages (May 2004)
Volume 61, Issue 6, Pages (June 2002)
Volume 54, Issue 1, Pages (July 1998)
Volume 72, Issue 2, Pages (July 2007)
The Case ∣ Acute renal failure and anemia
Volume 74, Issue 10, Pages (November 2008)
Volume 62, Issue 1, Pages (July 2002)
Nephrotoxicity of antiretroviral therapy in an HIV-infected patient
Acute interstitial nephritis
Michael Eikmans, Hans J. Baelde, Emile De Heer, Jan A. Bruijn 
Volume 67, Issue 1, Pages (January 2005)
Volume 61, Issue 1, Pages (January 2002)
Volume 53, Issue 5, Pages (May 1998)
Volume 71, Issue 10, Pages (May 2007)
Tubular biomarkers to assess progression of diabetic nephropathy
Volume 84, Issue 2, Pages (August 2013)
The clinical spectrum of tubulointerstitial nephritis
Volume 82, Issue 8, Pages (October 2012)
Volume 63, Issue 2, Pages (February 2003)
Volume 64, Pages S39-S45 (October 2003)
Volume 58, Issue 2, Pages (August 2000)
Activation of Erk1/2 and Akt following unilateral ureteral obstruction
Comorbidity and confounding in end-stage renal disease
Gregory B. Vanden Heuvel  Kidney International 
Volume 55, Issue 6, Pages (June 1999)
A novel classification for IgA nephropathy
Volume 81, Issue 1, Pages (January 2012)
Volume 87, Issue 2, (February 2015)
Takashi Ehara, Hidekazu Shigematsu  Kidney International 
Lymphatic vessels develop during tubulointerstitial fibrosis
Volume 60, Issue 1, Pages (July 2001)
R. Rajakariar, E.J. Sharples, M.J. Raftery, M. Sheaff, M.M. Yaqoob 
Volume 78, Issue 1, Pages (July 2010)
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
Volume 57, Issue 1, Pages (January 2000)
Role of CD8+ cells in the progression of murine adriamycin nephropathy
Volume 73, Issue 12, Pages (June 2008)
Volume 76, Issue 5, Pages (September 2009)
Modulating kidney transplant interstitial fibrosis and tubular atrophy: is the RAAS an important target?  Hatem Amer, Matthew D. Griffin  Kidney International 
Expression of connective tissue growth factor in human renal fibrosis
Volume 74, Issue 4, Pages (August 2008)
The Case | Idiopathic hypocomplementemic interstitial nephritis
Volume 83, Issue 6, Pages (June 2013)
Volume 70, Issue 6, Pages (September 2006)
IgG4-related tubulointerstitial nephritis
Dental caries in renal tubular acidosis
Volume 69, Issue 12, Pages (June 2006)
Volume 67, Issue 1, Pages (January 2005)
CD4+ T cells: a potential player in renal fibrosis
Nephrology Crossword: Glomerulonephritis
Volume 71, Issue 7, Pages (April 2007)
Volume 80, Issue 7, Pages (October 2011)
The treatment of acute interstitial nephritis: More data at last
Volume 74, Issue 9, Pages (November 2008)
Volume 65, Issue 2, Pages (February 2004)
The more or less ‘pristine’ renal allograft biopsy
J.S. Schlondorff, G.P. Mendez, H.G. Rennke, C.C. Magee 
The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?  Richard E. Gilbert, Mark E. Cooper  Kidney.
Volume 80, Issue 9, Pages (November 2011)
Volume 65, Issue 5, Pages (May 2004)
Presentation transcript:

Volume 73, Issue 12, Pages 1426-1433 (June 2008) GMP-17-positive T-lymphocytes in renal tubules predict progression in early stages of IgA nephropathy  L.A. van Es, E. de Heer, L.J. Vleming, A. van der Wal, M. Mallat, I. Bajema, J.A. Bruijn, J.W. de Fijter  Kidney International  Volume 73, Issue 12, Pages 1426-1433 (June 2008) DOI: 10.1038/ki.2008.66 Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 1 Interstitial histopathological characteristics of progressors vs non-progressors. The progression rate of each individual patient in group 1 with eGFR above 60 ml min-1 is expressed in relation to the presence or absence of interstitial fibrosis (a), tubular atrophy (b), and interstitial infiltration (c). The horizontal dotted line separates the progressors (progression rate ≥0.2 year-1) from non-progressors (progression rate <0.2 year-1). Kidney International 2008 73, 1426-1433DOI: (10.1038/ki.2008.66) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 2 Phenotype of infiltrating leukocytes. Progressors express CD45 (a), CD3 (c), CD20 (e), and α-SMA (g) in their biopsies. Arrows indicate intra-epithelial lymphocytes (c). CD45-positive leucocytes (a), CD20-positive B cells (e), and α-SMA are located in the interstitium. The images from non-progressors (b, d, f, h) do not show these abnormalities. Kidney International 2008 73, 1426-1433DOI: (10.1038/ki.2008.66) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 3 Phenotype and localizations of cytotoxic T-cells. HLA-DR expressed in proximal tubules in a biopsy of a progressor (a). CD8- (in red) and GMP-17 (in black)-positive cytotoxic T-lymphocytes within tubules (open arrows) and in the interstitium (closed arrows) of a progressor (b). The exact localization of double positive cells was sometimes unclear (c) (arrow with asterisk). The tubular basement membrane is delineated by the use of SR (e, f) to distinguish between intra-epithelial and interstitial GMP-17-positive (in black) lymphocytes. The images from non-progressors (b, d, f) do not show these abnormalities. Kidney International 2008 73, 1426-1433DOI: (10.1038/ki.2008.66) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 4 Correlation of cytotoxic T-cells with progression. The progression rate of each individual patient in group 1 with eGFR above 60 ml min-1 is expressed in relation to the presence or absence of CD8/GMP-17-positive lymphocytes in the interstitium (a) or in renal tubules (b). The relationship of progression rate to absence or presence of GMP-17-positive T-lymphocytes in the interstitium or in intact renal tubules using SR as a counterstain is shown in (c) and (d), respectively. The horizontal dotted line separates the progressors (progression rate ≥0.2 year-1) from non-progressors (progression rate <0.2 year-1). Kidney International 2008 73, 1426-1433DOI: (10.1038/ki.2008.66) Copyright © 2008 International Society of Nephrology Terms and Conditions